COVID-19 患者出院时的肺功能异常。
Abnormal pulmonary function in COVID-19 patients at time of hospital discharge.
机构信息
Dept of Respiratory Medicine, Guangzhou Eighth People's Hospital, Guangzhou, China.
Xiaoneng Mo, Wenhua Jian and Zhuquan Su are joint first authors.
出版信息
Eur Respir J. 2020 Jun 18;55(6). doi: 10.1183/13993003.01217-2020. Print 2020 Jun.
Abstract
相似文献
1
Abnormal pulmonary function in COVID-19 patients at time of hospital discharge.
Eur Respir J. 2020 Jun 18;55(6). doi: 10.1183/13993003.01217-2020. Print 2020 Jun.
2
Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic.
Mult Scler Relat Disord. 2020 Aug;43:102222. doi: 10.1016/j.msard.2020.102222. Epub 2020 May 23.
3
Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Respiration. 2020;99(8):649-657. doi: 10.1159/000507940. Epub 2020 Aug 25.
4
Impact of gender on extent of lung injury in COVID-19.
Clin Radiol. 2020 Jul;75(7):554-556. doi: 10.1016/j.crad.2020.04.005. Epub 2020 Apr 23.
5
Pulmonary function of patients with 2019 novel coronavirus induced-pneumonia: a retrospective cohort study.
Ann Palliat Med. 2020 Sep;9(5):3447-3452. doi: 10.21037/apm-20-1688.
6
Ultrasound in COVID-19: a timeline of ultrasound findings in relation to CT.
Clin Radiol. 2020 Jul;75(7):553-554. doi: 10.1016/j.crad.2020.04.003. Epub 2020 Apr 18.
7
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
8
The baby lung and the COVID-19 era.
Intensive Care Med. 2020 Jul;46(7):1438-1440. doi: 10.1007/s00134-020-06103-5. Epub 2020 May 25.
9
"No dose" lung ultrasound correlation with "low dose" CT scan for early diagnosis of SARS-CoV-2 pneumonia.
Intensive Care Med. 2020 Jun;46(6):1103-1104. doi: 10.1007/s00134-020-06058-7. Epub 2020 May 4.
10
Personalizing Invasive Mechanical Ventilation Strategies in Coronavirus Disease 2019 (COVID-19)-Associated Lung Injury: The Utility of Lung Ultrasound.
J Cardiothorac Vasc Anesth. 2020 Oct;34(10):2571-2574. doi: 10.1053/j.jvca.2020.04.062. Epub 2020 May 15.
引用本文的文献
1
Pulmonary Function Among COVID-19 Patients in Home Isolation Program.
Med Sci (Basel). 2025 Jul 9;13(3):88. doi: 10.3390/medsci13030088.
2
Case Report: Rehabilitation assessment and exercise using cardiopulmonary exercise test after coronavirus-disease pneumonia.
Front Rehabil Sci. 2025 Jul 4;6:1533239. doi: 10.3389/fresc.2025.1533239. eCollection 2025.
3
Home Spirometry for Post-COVID Recovery: A Clinical Validation Study of an Ultrasonic Device.
Diagnostics (Basel). 2025 May 30;15(11):1396. doi: 10.3390/diagnostics15111396.
4
The respiratory microbiome in patients with post-COVID-19 residual lung abnormalities resembles that of healthy individuals and is distinct from idiopathic pulmonary fibrosis.
ERJ Open Res. 2025 May 27;11(3). doi: 10.1183/23120541.00826-2024. eCollection 2025 May.
5
Longitudinal alterations of gut mycobiota during 2 years after COVID-19 and its correlation with pulmonary sequela.
Microbiol Spectr. 2025 Jul;13(7):e0300724. doi: 10.1128/spectrum.03007-24. Epub 2025 May 23.
6
Early nintedanib deployment in COVID-19 interstitial lung disease (ENDCOV-I): study protocol of a randomised, double-blind, placebo-controlled trial.
BMJ Open Respir Res. 2025 Apr 10;12(1):e002323. doi: 10.1136/bmjresp-2024-002323.
7
Long-term alveolar-capillary diffusion impairments after severe SARS-CoV-2 pneumonia.
Ann Med. 2025 Dec;57(1):2483383. doi: 10.1080/07853890.2025.2483383. Epub 2025 Mar 28.
8
The Predictive Role of C-Reactive Protein, Leukocyte Cell Count, and Soluble Urokinase Plasminogen Activator Receptor for Pulmonary Sequelae in Hospitalized COVID-19 Survivors: A Prospective Single-Center Cohort Study.
J Clin Med. 2025 Mar 4;14(5):1717. doi: 10.3390/jcm14051717.
9
The Association of Long COVID-19 Symptoms, Physical Function, and Activities of Daily Living Among Older Women.
J Am Geriatr Soc. 2025 Jun;73(6):1711-1721. doi: 10.1111/jgs.19434. Epub 2025 Mar 10.
10
Coronavirus Disease 2019 Case Series in China: Sequelae and Effectiveness of Vaccination and Antiviral Drugs.
Infect Drug Resist. 2025 Feb 25;18:1125-1133. doi: 10.2147/IDR.S499058. eCollection 2025.
本文引用的文献
1
Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study.
Radiology. 2020 Aug;296(2):E55-E64. doi: 10.1148/radiol.2020200843. Epub 2020 Mar 19.
2
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
3
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
4
Correlation between Pneumonia Severity and Pulmonary Complications in Middle East Respiratory Syndrome.
J Korean Med Sci. 2018 May 10;33(24):e169. doi: 10.3346/jkms.2018.33.e169. eCollection 2018 Jun 11.
5
The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status.
Respirology. 2010 Apr;15(3):543-50. doi: 10.1111/j.1440-1843.2010.01720.x. Epub 2010 Mar 19.
6
The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors.
Chest. 2005 Oct;128(4):2247-61. doi: 10.1378/chest.128.4.2247.
7
Follow-up study on pulmonary function and lung radiographic changes in rehabilitating severe acute respiratory syndrome patients after discharge.
Chest. 2005 Jun;127(6):2119-24. doi: 10.1378/chest.127.6.2119.
8
Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors.
Thorax. 2005 May;60(5):401-9. doi: 10.1136/thx.2004.030205.
Zotero 插件